SeaSpine, Implanet Form US Partnership with Jazz Spinal Devices

Implanet entered into a 6-year private label agreement with SeaSpine covering distribution of the Jazz® portfolio in the U.S.

SeaSpine will have exclusive rights to sell Jazz products under its own brand name, and the right to sell Jazz Cap®, a proprietary implant developed to treat degenerative spinal trauma, upon FDA clearance.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us